Smart Rich Information

The number of orders of medicines in Canada knew a rise of a few more of 6% in 2007, but the Canadian pharmaceutical industry knew a slightly lower growth to the one of the past years.

It is what the data of an analyse1 achieved by IMS Health Canada, the main world supplier of commercial information of the sectors of the pharmaceutical industry and the care of health, reveal.

In 2007, 422.6 million of orders have been executed in the pharmacies to Canada, compared to about 398 million in 2006 and 374 million in 2005.

From where does the light bending of the growth of the profits of the pharmaceuticals come? To the rise of the sale of the generic medicines. These last are used in replacement of the mark medicines because of their less elevated cost.

Indeed, the number of generic products delivered on order increased 14% globally in 2007, while the sale of the medicines accused mark a decrease of 0.2% during the same year.

The medicines the most frequently sold on order are those acting against the cardiovascular illnesses, follow-ups closely by the antidepressants, then the gastro-intestinal and genito-urinary agents.

Globally, the growth of the number of orders maintains itself at the country. Every year, the Canadian physicians prescribe about 6% more than medicines to the course of the previous year.

The selling price of the pharmaceutical products however decreased slightly because the patents of exclusive rights of several medicines of mark expired in 2007. From one year to the next, the Canadians consume more medicines and dedicate a sum there always increasing.

convert this post to pdf.